62 employees
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.
$215M sweet spot round size
2014
$215M
from 2 investors over 1 rounds
Atea Pharmaceuticals, Inc raised $215M on June 20, 2020
Investors: Bain Capital Life Sciences and + 11 Other investors